Phase 2 Open-Label Study of Sacituzumab Govitecan as Second-Line Therapy in Patients With Extensive-Stage SCLC: Results From TROPiCS-03
Afshin Dowlati, Anne C. Chiang, Andrés Cervantes, Sunil Babu, Erika Hamilton, Shu Fen Wong, Andrea Tazbirkova, Ivana Sullivan, Cédric van Marcke, Antoîne Italiano, Jilpa Patel, Sabeen Mekan, Tia Wu, Saiama N. Waqar
Topics & Concepts
MedicineStage (stratigraphy)TropicsLung cancerFirst line therapyOncologyCancerPhase (matter)Internal medicineFisheryChemistryOrganic chemistryBiologyPaleontologyLung Cancer Research StudiesPARP inhibition in cancer therapyAdvanced Breast Cancer Therapies